Physical Medicine & Rehabilitation · Greensboro, NC
NPI
1629268149
Since 2007
Specialty
Physical Medicine & Rehabilitation
Code 208100000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1126 N Church St Ste 103
Greensboro, NC, 27401
Phone (336) 663-4900
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
710 services
Medicare patients, 2024
165
Average age 71
Drug cost, 2024
$135K
2,237 prescriptions
Company payments, 2025
$692
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Megan B Lovorn was code 99232 (hospital e&m - subsequent), 221 times for 69 patients. In total Megan B Lovorn billed 710 services in 21 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 221 | 69 | $57.32 | $13K |
| 99233 Hospital E&M - Subsequent | Facility | 139 | 43 | $86.18 | $12K |
| 99231 Hospital E&M - Subsequent | Facility | 81 | 40 | $35.75 | $2,896 |
| 99214 Office E&M - Established | Facility | 56 | 34 | $59.64 | $3,340 |
| 99222 Hospital E&M - Initial | Facility | 47 | 47 | $94.78 | $4,455 |
| 99213 Office E&M - Established | Facility | 37 | 23 | $44.66 | $1,652 |
| 99239 Hospital Discharge Management | Facility | 27 | 26 | $82.04 | $2,215 |
| 99215 Office E&M - Established | Facility | 20 | 17 | $90.26 | $1,805 |
| 20553 Musculoskeletal | Facility | 20 | 12 | $24.52 | $490 |
| 99238 Hospital Discharge Management | Facility | 15 | 15 | $60.32 | $905 |
By year: 2022 $56K for 952 services; 2023 $53K for 901 services; 2024 $44K for 710 services.
Medicare prescription drug claims, 2024
In 2024, the drug Megan B Lovorn prescribed most often to Medicare patients was Gabapentin, with 278 prescriptions and refills. In total Megan B Lovorn wrote 2,237 Medicare prescriptions that cost $135K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 278 | 397 | 55 | $5,264 |
| Baclofen Generic | 168 | 297 | 50 | $5,004 |
| Tramadol Hcl Generic | 159 | 160 | 34 | $1,552 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 152 | 152 | 33 | $5,442 |
| Duloxetine Hcl Generic | 146 | 259 | 36 | $3,714 |
| Tizanidine Hcl Generic | 104 | 150 | 23 | $1,162 |
| Pregabalin Generic | 88 | 116 | 19 | $1,598 |
| Dantrolene Sodium Generic | 73 | 112 | 16 | $11K |
| Oxycodone Hcl Generic | 68 | 69 | 18 | $1,678 |
| Trazodone Hcl Generic | 64 | 102 | 17 | $255 |
| Diclofenac Sodium Generic | 57 | 70 | Under 11 | $779 |
| Cyclobenzaprine Hcl Generic | 51 | 57 | 15 | $940 |
| Methocarbamol Generic | 44 | 58 | 13 | $870 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 44 | 44 | Under 11 | $1,421 |
| Lidocaine Generic | 39 | 40 | 13 | $6,969 |
Brand drugs: 142 claims; generic drugs: 2,095 claims; opioid claims: 536.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Megan B Lovorn $692 ($692 in general payments such as food, travel and fees) from 12 companies. The largest payer was Medtronic, Inc. with $106.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 2 | $106 |
| Lundbeck LLC | 3 | $82.22 |
| Vertex Pharmaceuticals Incorporated VRTX | 4 | $80.76 |
| Tonix Medicines, Inc. | 1 | $67.35 |
| Abbvie Inc. ABBV | 3 | $64.14 |
| Averitas Pharma Inc. | 2 | $61.44 |
| Collegium Pharmaceutical, Inc. COLL | 3 | $58.6 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $54.67 |
| Abbott Laboratories ABT | 2 | $48.11 |
| Xeris Pharmaceuticals, Inc. | 1 | $37.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.